GlassScriptPhysician profile
Annabelle Lopez
NPI 1871796862
$6,328.93
in general payments reported to CMS, 2019-2025
22 companies · $3,958 in 2025
The $3,958 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $106 · 2021: $258 · 2022: $496 · 2023: $211 · 2024: $1,195 · 2025: $3,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,367 · Food and Beverage: $1,422 · Travel and Lodging: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,366.83 |
| Food and Beverage | $1,421.95 |
| Travel and Lodging | $575.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,093.67 | 2024-2025 | |
| Revance Therapeutics, INC. | $438.06 | 2025 | Daxxify, Daxi |
| Abbvie INC. | $423.66 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $323.65 | 2021-2025 | |
| Evofem Biosciences, INC. | $164.50 | 2022-2025 | Phexxi, Solosec, Phexx |
| Galderma Laboratories, L.P. | $118.08 | 2022 | |
| Hologic Sales and Service, LLC | $117.74 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Shield Therapeutics INC | $103.53 | 2024 | |
| Astellas Pharma US INC | $83.09 | 2023-2024 | Veozah |
| Amag Pharmaceuticals, INC. | $77.78 | 2019-2021 | |
| Exeltis, USA INC. | $57.16 | 2022-2025 | Slynd |
| Organon LLC | $54.64 | 2024-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $54.63 | 2023 | Myfembree |
| Baxter Healthcare | $44.64 | 2025 | Perclot |
| Allergan, INC. | $37.05 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $27.13 | 2019 | |
| Myovant Sciences INC. | $26.96 | 2022 | |
| Merck Sharp & Dohme LLC | $20.82 | 2020 | |
| Pfizer INC. | $16.99 | 2020 | |
| Becton, Dickinson and Company | $16.53 | 2025 | Arista |
| Davol INC. | $14.39 | 2024 | Arista Ah Flexitip |
| Ferring Pharmaceuticals INC. | $14.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annabelle Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.